132
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Silencing of CRT relieves Ang II-Induced injury of HUVECs with insulin resistance

, , &
Pages 321-330 | Received 15 Apr 2020, Accepted 06 Aug 2020, Published online: 01 Sep 2020

References

  • Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol. 2013;75:155–179.
  • Villalobos-Labra R, Subiabre M, Toledo F, et al. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Mol Aspects Med. 2019;66:49–61.
  • Janus A, Szahidewicz-Krupska E, Mazur G, et al. Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediators Inflamm. 2016;2016:3634948.
  • Kaji K, Yoshiji H, Ikenaka Y, et al. Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress. Curr Med Chem. 2012;19(12):1889–1898.
  • Radenkovic M, Stojanović M, Nešić IM, et al. Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications. Indian J Med Res. 2016;144(2):154–168.
  • Tąpolska M, Spałek M, Szybowicz U, et al. Arterial stiffness parameters correlate with estimated cardiovascular risk in humans: a clinical study. IJERPH. 2019;16(14):2547.
  • Graus-Nunes F, Souza-Mello V. The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis. Biomed Pharmacother. 2019;109:639–645.
  • Suliburska J, Skrypnik K, Szulińska M, et al. Diuretics, Ca-antagonists, and angiotensin-converting enzyme inhibitors affect zinc status in hypertensive patients on monotherapy: a randomized trial. Nutrients. 2018;10(9):1284.
  • Suliburska J, Skrypnik K, Szulińska M, et al. Effect of hypotensive therapy combined with modified diet or zinc supplementation on biochemical parameters and mineral status in hypertensive patients. J Trace Elem Med Biol. 2018;47:140–148.
  • Tunçdemir M, Ozturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. J Mol Histol. 2008;39(6):605–616.
  • Habibi J, Aroor AR, Das NA, et al. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat. Cardiovasc Diabetol. 2019;18(1):40.
  • Wang J, Feng Y, Huo H, et al. NLRP3 inflammasome mediates angiotensin II-induced islet β cell apoptosis. Acta Biochim Biophys Sin (Shanghai). 2019;51(5):501–508.
  • Migliaccio AR, Uversky VN. Dissecting physical structure of calreticulin, an intrinsically disordered Ca2+-buffering chaperone from endoplasmic reticulum. J Biomol Struct Dyn. 2018;36(6):1617–1636.
  • Wang WA, Liu WX, Durnaoglu S, et al. Loss of calreticulin uncovers a critical role for calcium in regulating cellular lipid homeostasis. Sci Rep. 2017;7(1):5941.
  • Oyadomari S, Takeda K, Takiguchi M, et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA. 2001;98(19):10845–10850.
  • Feng M, Marjon KD, Zhu F, et al. Programmed cell removal by calreticulin in tissue homeostasis and cancer. Nat Commun. 2018;9(1):3194–3194.
  • Jo SH, Choi JA, Lim YJ, et al. Calreticulin modulates the intracellular survival of mycobacteria by regulating ER-stress-mediated apoptosis. Oncotarget. 2017;8(35):58686–58698.
  • Bao Q, Chen L, Li J, et al. Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II. Cell Mol Biol (Noisy-le-Grand). 2017;63(4):23–27.
  • Son M, Chan CB, Wu J. Egg white ovotransferrin-derived ACE inhibitory peptide ameliorates Angiotensin II-stimulated insulin resistance in skeletal muscle cells. Mol Nutr Food Res. 2018;62(4):1700602.
  • Khanna A, English SW, Wang XS, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377(5):419–430.
  • Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–647.
  • Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.
  • Ling HY, Hu B, Hu XB, et al. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Exp Clin Endocrinol Diabetes. 2012;120(9):553–559.
  • Chen F, Chen B, Xiao FQ, et al. Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells. Cell Physiol Biochem. 2014;33(4):1058–1074.
  • Wang X, Yu C, Zhang B, et al. The injurious effects of hyperinsulinism on blood vessels. Cell Biochem Biophys. 2014;69(2):213–218.
  • Tian M, Lin X, Wu L, et al. Angiotensin II triggers autophagy and apoptosis in PC12 cell line: an in vitro Alzheimer's disease model. Brain Res. 2019;1718:46–52.
  • Wang J, Yue J, Xia Q, et al. Angiotensin II type i receptor agonistic autoantibodies induces apoptosis of cardiomyocytes by downregulating miR21 in preeclampsia: a mechanism study. Am J Transl Res. 2019;11(4):2339–2349.
  • Jacques D, Provost C, Normand A, et al. Angiotensin II induces apoptosis of human right and left ventricular endocardial endothelial cells by activating the AT(2) receptor (1). Can J Physiol Pharmacol. 2019;97(6):581–588.
  • Song J, Huang S, Wang K, et al. Long non-coding RNA MEG3 attenuates the angiotensin II-induced injury of human umbilical vein endothelial cells by interacting with p53. Front Genet. 2019;10:78.
  • Jin LW, Pan M, Ye HY, et al. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Exp Physiol. 2019;104(2):220–230.
  • Li S, Zhu Z, Xue M, et al. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1241–1252.
  • Chen YP, Sivalingam K, Shibu MA, et al. Protective effect of Fisetin against angiotensin II-induced apoptosis by activation of IGF-IR-PI3K-Akt signaling in H9c2 cells and spontaneous hypertension rats. Phytomedicine. 2019;57:1–8.
  • Gao M, Du Y, Xie JW, et al. Redox signal-mediated TRPM2 promotes Ang II-induced adipocyte insulin resistance via Ca2+-dependent CaMKII/JNK cascade. Metab Clin Exp. 2018;85:313–324.
  • Totary-Jain H, Naveh-Many T, Riahi Y, et al. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ Res. 2005;97(10):1001–1008.
  • Cai W, Zhong S, Zheng F, et al. Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1/ERK1/2/RSK1 pathway. IUBMB Life. 2019;71(2):261–276.
  • Zhang W, Liu Z, Zhang Y, et al. Silencing calreticulin gene might protect cardiomyocytes from angiotensin II-induced apoptosis. Life Sci. 2018;198:119–127.
  • Fan X, Yao Y, Zhang Y. Calreticulin promotes proliferation and extracellular matrix expression through Notch pathway in cardiac fibroblasts. Adv Clin Exp Med. 2018;27(7):887–892.
  • Jiao Y, Ding H, Huang S, et al. Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis. Clin Exp Rheumatol. 2018;36(5):841–849.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.